Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Ashley N. Brown, PhD (she/her/hers)

Associate Professor
University of Florida
Orlando, FL, United States

Dr. Ashley Brown joined the University of Florida as an Assistant Professor at the Institute for Therapeutic Innovation (ITI) in August 2011. In 2014, she became the Program Director for the Antiviral Pharmacodynamics Laboratory at ITI. Dr. Brown graduated cum laude with her B.A. in microbiology from Miami University in Oxford, OH in 2003 and later received her Ph.D. from the University at Albany, State University of New York under the supervision of Dr. Kristen Bernard in 2008. Upon completion of her Ph.D., she became the Deputy Lab Chief of the Antiviral Pharmacodynamics laboratory at Ordway Research Institute in Albany, NY.

Dr. Brown’s research focuses on designing optimized therapeutic regimens for antiviral compounds active against viruses that pose a significant threat to global public health. She is the author of 34 publications in many top tier peer-reviewed journals including mBio, The Journal of Infectious Diseases, Scientific Reports, and Antimicrobial Agents and Chemotherapy. She has also published a book chapter in “Applied Pharmacometrics”, as part of an AAPS series on advancing Pharmaceutical Sciences. She served as the principal investigator on an R01 from NIAID for “Optimizing Combination Therapy for Hepatitis C virus with pharmacodynamic models”. Dr. Brown has also received funding from the Florida Department of Health to investigate potential antiviral strategies for the treatment of Zika virus as well as the University of Florida to study optimal dosing strategies for antivirals active against dengue virus and to identify dengue virus protease inhibitors using a structure-based discovery platform. Her research is currently focused on identifying optimal therapeutic strategies with antivirals and other effective medical countermeasures to combat SARS-CoV-2, the causative agent of COVID-19.

Dr. Brown serves on the editorial board for the peer-reviewed journal Antimicrobial Agents and Chemotherapy and is an ad hoc reviewer for many journals including Scientific Reports, pLos Neglected Tropical Diseases, Antiviral Research, and Nature Communications among others. Dr. Brown is the recipient of the University of Florida’s Excellence Award for Assistant Professors as well as the University of Florida’s Term Professorship Award for outstanding academic and research achievements.

Disclosure(s): No financial relationships to disclose

Presentation(s):